1-10 of 10
Amira Adly
Close
Sort by
Journal Articles

Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)

Mohsen Saleh Elalfy, Amal El-Beshlawy, Amira Adly, Fatma Soliman Elsayed Ebeid, Caroline Fradette, David Lee, Noemi T Temin, Fernando Tricta, Anna Rozova, Mona Hamdy
Journal: Blood
Blood (2021) 138 (Supplement 1): 3070.
https://doi.org/10.1182/blood-2021-147595
Published: 2021
Journal Articles

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Fatma Soliman Elsayed Ebeid, Amal El-Beshlawy, Neveen Salama, Mona Hamdy
Journal: Blood
Blood (2021) 138 (Supplement 1): 3071.
https://doi.org/10.1182/blood-2021-149359
Published: 2021
Journal Articles

A Prospective Observational Multicenter Study on Deferiprone & Deferasirox in Clinical Practice of Pediatric Patients with Transfusion-Dependent B-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Tamer Hassan, Mohamed Maebid, Rasha el Ashry, Khaled Sayeh, S Regab, Amal Elbeshlawy, Mona Hamdy, M Elshanshoury, Omar Elalfy, S Shehata, M EL Hawy, S Abd el Helim, Eman El Askary, N Shahein
Journal: Blood
Blood (2021) 138 (Supplement 1): 5044.
https://doi.org/10.1182/blood-2021-149462
Published: 2021
Journal Articles

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Mohamed Abd el mohsen, Maha Saber, Amira Adly, Eman Ismail, Omar Elalfy, MD, Elghamry Islam, Fatma Ibrahim, Mohsen Saleh Elalfy, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1058.
https://doi.org/10.1182/blood-2018-99-115186
Published: 2018
Journal Articles

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Mohsen Saleh Elalfy, MD, Vasilios Berdoukas, MB, BS, Fernando Tricta, MD, Amira Adly, Nyeria Hazza, Hanem Awed, Basma Helal, Mohamed Tarif Salam
Journal: Blood
Blood (2016) 128 (22): 1286.
https://doi.org/10.1182/blood.V128.22.1286.1286
Published: 2016
Journal Articles

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study with Genotype - Phenotype Correlation

Mohsen Saleh Elalfy, Amira Adly, Lorena Duca, Tarek Kamal
Journal: Blood
Blood (2015) 126 (23): 4534.
https://doi.org/10.1182/blood.V126.23.4534.4534
Published: 2015
Journal Articles

Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload

Mohsen Saleh Elalfy, Maha Saber, Amira Adly, Eman Ismail, Mohamed Tarif, Fatma Ibrahim, Omar Elalfy
Journal: Blood
Blood (2014) 124 (21): 4046.
https://doi.org/10.1182/blood.V124.21.4046.4046
Published: 2014
Journal Articles

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Mohsen Saleh Elalfy, Yasser Wali, MD, FRCPCH, (UK), S Tony, Ahmed Samir, Amira Adly
Journal: Blood
Blood (2013) 122 (21): 559.
https://doi.org/10.1182/blood.V122.21.559.559
Published: 2013
Journal Articles

Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients

Mohsen Saleh Elalfy, Amira Adly, Yassmine Elhanawy
Journal: Blood
Blood (2012) 120 (21): 252.
https://doi.org/10.1182/blood.V120.21.252.252
Published: 2012
Journal Articles

Effect of Antioxidant Therapy On Hepatic Fibrosis and Liver Iron Concentrations In Beta-Thalassemia Major Patients

Mohsen Saleh Elalfy, Atef Attia, Abd El Basat Sayed, Fatma Ibrahim, Amer Mohammed, Amira Adly
Journal: Blood
Blood (2011) 118 (21): 5292.
https://doi.org/10.1182/blood.V118.21.5292.5292
Published: 2011